E Mattila
Overview
Explore the profile of E Mattila including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oksi J, Aalto A, Saila P, Partanen T, Anttila V, Mattila E
Eur J Clin Microbiol Infect Dis
. 2019 Jul;
38(10):1947-1952.
PMID: 31359254
Reports on real-world experience on efficacy of bezlotoxumab (BEZ) has been lacking thus far. We retrospectively studied the efficacy and safety of BEZ in preventing the recurrence of Clostridium difficile...
2.
Draper L, Ryan F, Smith M, Jalanka J, Mattila E, Arkkila P, et al.
Microbiome
. 2018 Dec;
6(1):220.
PMID: 30526683
Background: Faecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium difficile infection. Its success is typically attributed to the restoration of a diverse microbiota. Viruses (including bacteriophages)...
3.
Jalanka J, Hillamaa A, Satokari R, Mattila E, Anttila V, Arkkila P
Aliment Pharmacol Ther
. 2017 Dec;
47(3):371-379.
PMID: 29226561
Background: Faecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection. In short-term the treatment has been shown to be safe, however, there are no large, long-term...
4.
Satokari R, Mattila E, Kainulainen V, Arkkila P
Aliment Pharmacol Ther
. 2015 May;
41(3):321.
PMID: 25945590
No abstract available.
5.
Satokari R, Mattila E, Kainulainen V, Arkkila P
Aliment Pharmacol Ther
. 2014 Oct;
41(1):46-53.
PMID: 25355279
Background: Faecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (rCDI). The finding of suitable donor, donor screening and preparation of faecal transplants are challenging in...
6.
Mattila E, Arkkila P, Mattila P, Tarkka E, Tissari P, Anttila V
Aliment Pharmacol Ther
. 2012 Oct;
37(1):122-8.
PMID: 23095030
Background: Clostridium difficile can cause severe antibiotic-associated colitis. Conventional treatments with metronidazole and vancomycin improve symptoms, but after discontinuation of treatment, C. difficile infection (CDI) recurs in a number of...
7.
Hognas G, Tuomi S, Veltel S, Mattila E, Murumagi A, Edgren H, et al.
Oncogene
. 2011 Nov;
31(31):3597-606.
PMID: 22120710
Aneuploidy is frequently detected in solid tumors but the mechanisms regulating the generation of aneuploidy and their relevance in cancer initiation remain under debate and are incompletely characterized. Spatial and...
8.
Korhonen I, Mattila E, Ahtinen A, Salminen J, Hopsu L, Lappalainen R, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2009 Dec;
2009:316-9.
PMID: 19964216
Poor lifestyles - overweight, unhealthy diet, physical inactivity, sleep deprivation, and stress - are significant risk factors to chronic illnesses, which cause majority of the health care costs. Hence, behavioral...
9.
Mattila E, Korhonen I, Lappalainen R, Ahtinen A, Hopsu L, Leino T
Annu Int Conf IEEE Eng Med Biol Soc
. 2009 Jan;
2008:5846-50.
PMID: 19164047
Majority of the health risks and diseases in the modern world are related to lifestyles, e.g., overweight, unhealthy diet, physical inactivity, sleep deprivation, and stress. Behavioral change towards healthy lifestyles...
10.
Lyytikainen O, Mentula S, Kononen E, Kotila S, Tarkka E, Anttila V, et al.
Euro Surveill
. 2007 Nov;
12(11):E071108.2.
PMID: 18005648
No abstract available.